Cladribine has potential in multiple sclerosis, but is not without toxicity

[1] Bryson H.M., Sorkin E.M., Cladribine: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in haematological malignancies, Drugs, 46, pp. 872-894, (1993)

[2] Cladribine and pentostatin improve the outlook in hairy cell leukaemia, Drugs Ther Perspect, 3, 3, pp. 4-7, (1994)

[3] Langtry H.D., Lamb H.M., Cladribine: A review of its use in multiple sclerosis, BioDrugs, 9, 5, pp. 419-433, (1998)

[4] Beutler E., Sipe J.C., Romine J.S., Et al., The treatment of chronic progressive multiple sclerosis with cladribine, Proc Natl Acad Sci U S A, 93, pp. 1716-1720, (1996)

[5] Rice G., Cladribine and chronic progressive multiple sclerosis: The results of a multicenter trial, Neurology, 48, (1997)

[6] Grieb P., Ryba M., Stelmasiak Z., Et al., Cladribine treatment of multiple sclerosis, Lancet, 344, (1994)

[7] Glatiramer acetate: Promise in relapsing-remitting multiple sclerosis, Drugs Ther Perspect, 11, 10, pp. 1-5, (1998)

[8] Hauser S.L., Multiple sclerosis and other demyelinating diseases, Harrison's Principles of Internal Medicine, 2, pp. 2287-2295, (1994)

[1] Bryson H.M., Sorkin E.M., Cladribine: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in haematological malignancies, Drugs, 46, pp. 872-894, (1993)

[2] Cladribine and pentostatin improve the outlook in hairy cell leukaemia, Drugs Ther Perspect, 3, 3, pp. 4-7, (1994)

[3] Langtry H.D., Lamb H.M., Cladribine: A review of its use in multiple sclerosis, BioDrugs, 9, 5, pp. 419-433, (1998)

[4] Beutler E., Sipe J.C., Romine J.S., Et al., The treatment of chronic progressive multiple sclerosis with cladribine, Proc Natl Acad Sci U S A, 93, pp. 1716-1720, (1996)

[5] Rice G., Cladribine and chronic progressive multiple sclerosis: The results of a multicenter trial, Neurology, 48, (1997)

[6] Grieb P., Ryba M., Stelmasiak Z., Et al., Cladribine treatment of multiple sclerosis, Lancet, 344, (1994)

[7] Glatiramer acetate: Promise in relapsing-remitting multiple sclerosis, Drugs Ther Perspect, 11, 10, pp. 1-5, (1998)

[8] Hauser S.L., Multiple sclerosis and other demyelinating diseases, Harrison's Principles of Internal Medicine, 2, pp. 2287-2295, (1994)